Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- How are synapses affected by Alzheimer's disease?
- Alzheimer's disease
- The healthy brain
- Healthy and AD brain
- Pathological hallmarks of AD
- AD risk factors
- Extensive preclinical trajectory in AD
- Modifying the trajectory of AD
- Neuron anatomy
- Synapse loss in AD
- Studying Alzheimer's disease
- Models for studying AD
- Mutant APP in mice leads to plaques
- Neuronal and synaptic defects
- How does AD affect the function of brain cells and their connections?
- A-beta is toxic to neurons and synapses: death of neurons
- A-beta is toxic to neurons and synapses: loss of dendritic spines
- A-beta is toxic to neurons and synapses: impair synaptic plasticity
- Neuronal communication
- Synaptic plasticity
- Tau is required for A-beta function
- Is synaptic plasticity affected by A-beta in vivo?
- Chronic effects of A-beta in a mature brain
- Emergence of synaptic and cognitive impairment in an inducible APP model
- Emergence of synaptic and cognitive impairment in inducible mouse model of AD
- Early impairment of synaptic plasticity
- How does A-beta affect neuronal function?
- A-beta causes defects in axonal transport
- A-beta affects multiple synaptic functions
- A-beta-mediated synapse loss
- Plasma membrane disruption
- Synaptic removal of AMPAR
- Caspase-3
- A-beta causes tau protein re-distribution
- A-beta causes excitotoxicity
- Challenges ahead: AD drug targets
- Challenges ahead: preclinical research
- Thank you
Topics Covered
- Alzheimer's disease and how does it affect the brain
- Causes for Alzheimer's disease
- Tools available to study the effects of Alzheimer's disease in synapses
- How Alzheimer's disease affects synapses and synaptic plasticity
- Candidate Alzheimer's disease mechanisms discovered in mouse models
- Challenges to translate this knowledge into therapies
Talk Citation
Vargas-Caballero, M. (2021, February 24). How are synapses affected by Alzheimer's disease? [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/VGXE3493.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
A selection of talks on Neurology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, I'm Mariana Vargas Caballero from the University of Southampton.
My talk today is entitled: 'How are synapses affected by Alzheimer's disease?'
0:11
My talk will be divided into three sections.
The first will deal with the basics,
what is Alzheimer's disease?
The second will deal with studying the disease.
What tools are available to research Alzheimer's disease?
The third section will ask:
how does Alzheimer's disease affect the function of brain cells and their connections,
and how can we use this knowledge?
Let's get started. Alzheimer's disease.
0:39
Our brain allows our body and mind to function.
The human brain is made of billions of cells.
Neurons are the excitable cells of the brain.
Together, they form brain networks that
together give us the capacity to learn and remember.
Synapses are the points of communication between
neurons, and communicate with substances called neurotransmitters.
For example, synapses that communicate via glutamate and
acetylcholine are very much affected in Alzheimer's disease.
Other cell types such as glia, astrocytes,
and microglia clear away debris and help keep neurons healthy.
These cell types go into overdrive during the disease.
The vascular system is necessary to allow the blood supply that
provides nutrients, and meets the high energy requirements of the brain.
1:30
Alzheimer's disease is the most common form of dementia in old people.
One in five people between 85 and 89 years old
will develop dementia. With age expectancy rate rising,
this disease is becoming more prevalent and we have a pressing need to find a cure.
Clinically, the disease is characterized by memory loss.
People gradually lose their ability to think,
remember, make decisions, and function independently.
Sadly, Alzheimer's disease is progressive and we still don't have a cure for it.
The diagrams on the top show that the brain in Alzheimer's disease shrinks.
This is because of extensive cell loss in the brain.
In particular, we have extensive neuron loss in the hippocampus,
which is a brain area that is essential for forming new memories.
At the microscopic level,
we can see that clumps of molecules accumulate inside and outside neurons.
We now know that these are the pathological hallmarks of Alzheimer's disease.